GRI Bio, Inc. is a biotechnology company in the healthcare sector trading on XNAS, led by CEO W. Marc Hertz, with a market cap of $3.6M.
Based on Q1 2026 filing
Common questions about GRI Bio, Inc.
GRI Bio, Inc. (GRI) has a market capitalization of $3.6M and trades on XNAS.